Scott Spector
President SIRO Europe

Scott L. Spector is President SIRO Europe. Mr. Spector joined SIRO in May 2009 and brings 15 years of international CRO experience. At SIRO Europe his leadership responsibilities include corporate development, finance, legal and organizational development.

Prior to joining SIRO, Mr. Spector served as General Manager of AAI Pharma France and Chief Executive Officer of AAI Oncology which is an oncology focused Contract Research Organization headquartered in Paris, France. In this role, Mr. Spector was responsible for the strategic direction of the oncology operations, business development and clinical operations.

Before joining AAI Pharma, Mr. Spector was at Quintiles Transnational Corp., where he held positions of increasing responsibility over a nine-year period, serving as General Manager for their Paris, France office and global finance director for the CNS and Anti Infective business units. Mr. Spector played a key role in integrating newly acquired businesses, growing operations, implementing business management practices and improving operating efficiencies.

Mr. Spector holds a BS/BA in Finance from Boston University.